Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/30/2010US7842856 Herbicide resistance gene, compositions and methods
11/30/2010US7842853 Transgenic plants synthesizing high amylose starch
11/30/2010US7842851 Floral transition genes in maize and uses thereof
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842796 PUFA polyketide synthase systems and uses thereof
11/30/2010US7842792 Compositions and methods for non-targeted activation of endogenous genes
11/30/2010US7842788 Metalloproteinase specific immunoglobulin for use in treatment and prevention of degradative diseases of connective tissue
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842786 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
11/30/2010US7842785 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842667 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
11/30/2010US7842502 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010US7842500 Anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
11/30/2010US7842497 Production of isoprenoids
11/30/2010US7842488 Polynucleotides encoding a human 3-phosphoinositide- dependent protein kinase
11/30/2010US7842487 using a three-dimensional matrix based on a benzyl ester of hyaluronic acid (HYAFF) for the preparation of a graft to be surgically implanted into a joint cartilage damaged by or to be protected against a degenerative and/or inflammatory pathology
11/30/2010US7842480 Protein fusion comprising transport domain for use in treatment and prevention of viral inection and cell proliferative disorders
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2296760C Strong early seed-specific gene regulatory region
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2189740C Transgenic arthritic mice
11/30/2010CA2144328C Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
11/25/2010WO2010135655A2 Human skin substitutes expressing il-12
11/25/2010WO2010135639A2 Compositions and methods for promoting beta cell maturity
11/25/2010WO2010135610A2 Cell therapy for brain tissue damage
11/25/2010WO2010135608A1 Methods for diagnosis, prognosis and methods of treatment
11/25/2010WO2010135603A2 Method for cancer detection, diagnosis and prognosis
11/25/2010WO2010135491A2 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010WO2010135401A2 Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
11/25/2010WO2010135299A1 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways
11/25/2010WO2010135255A1 Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseases
11/25/2010WO2010134619A1 Method for inducing differentiation of artificial pluripotent stem cells into epithelial progenitor cells, stem cells and corneal epithelial cells
11/25/2010WO2010134606A1 Method for inducing differentiation of embryonic stem cells or artificial pluripotent stem cells
11/25/2010WO2010134526A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
11/25/2010WO2010134519A1 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
11/25/2010WO2010134076A1 Method and system for somatic cell nuclear transfer
11/25/2010WO2010133853A1 Synthetic graft
11/25/2010WO2010133740A1 Mps cell genetically modified to overexpress ngal and the use thereof as a drug
11/25/2010WO2010103475A3 Use of serine protease inhibitors in the treatment of neutropenia
11/25/2010WO2010097793A3 Isolated populations of renal stem cells and methods of isolating and using same
11/25/2010WO2010090513A3 Culture medium for epithelial stem cells and organoids comprising said stem cells.
11/25/2010WO2010083203A3 Non-embryonic stem cells and uses thereof
11/25/2010WO2010079994A3 Anti-cancer drug screening method using rorα
11/25/2010WO2010068728A3 Engineering functional tissue from cultured cells
11/25/2010WO2010065876A3 Methods and compositions related to th-1 dendritic cells
11/25/2010WO2010056808A3 Compositions and methods for re-programming and re-differentiating cells
11/25/2010WO2010053238A3 Apparatus for realizing three-dimensional neural network
11/25/2010WO2009058983A3 Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
11/25/2010US20100299789 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation
11/25/2010US20100299788 Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same
11/25/2010US20100299784 Promoter, promoter control elements, and combinations, and uses thereof
11/25/2010US20100299783 Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same
11/25/2010US20100299782 Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
11/25/2010US20100299776 Soybean cultivar 8023330
11/25/2010US20100299774 Soybean cultivar 8837234
11/25/2010US20100299772 Soybean cultivar 8249120
11/25/2010US20100299771 MEANS AND METHODS FOR shRNA MEDIATED CONDITIONAL KNOCKDOWN OF GENES
11/25/2010US20100299770 Targeted cell death
11/25/2010US20100299769 Novel peptide involved in energy homeostasis
11/25/2010US20100299768 Reversible siRNA-Based Silencing of Mutant and Endogenous Wild-Type Huntingtin Gene and its Application for the Treatment of Huntington's Disease
11/25/2010US20100299766 Mouse models carrying a knock-out mutation of the qpctl-gene
11/25/2010US20100299765 Modalities for the treatment of degenerative diseases of the retina
11/25/2010US20100298545 EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
11/25/2010US20100298544 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
11/25/2010US20100298543 Mammalian zcytor 11
11/25/2010US20100298434 Neuroprotection and prevention of dopaminergic cell death by targeting nur77 translocation
11/25/2010US20100298425 Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Familial Dysautonomia
11/25/2010US20100298410 MICROMIRs
11/25/2010US20100298409 Compositions comprising stat3 sirna and methods of use thereof
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298407 Compositions and methods featuring micronas for treating neoplasia
11/25/2010US20100298406 Method of suppressing tumour growth
11/25/2010US20100298405 Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
11/25/2010US20100298404 Translocation and mutant ROS kinase in human non-small cell lung carcinoma
11/25/2010US20100298339 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/25/2010US20100298320 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
11/25/2010US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors
11/25/2010US20100298313 Method of using imidazolothiazole compounds for the treatment of disease
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298281 Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer
11/25/2010US20100298280 Compounds for the Modulation of Huntingtin Aggregation, Methods and Means for Identifying Such Compounds
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298235 Epithelial cell growth promoter
11/25/2010US20100298234 Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient
11/25/2010US20100298220 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010US20100298217 Csf-1r mutants
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100298204 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
11/25/2010US20100298203 Sdf-i-based glycosaminoglycan antagonists and methods of using same
11/25/2010US20100298200 Compounds and assays for controlling Wnt activity
11/25/2010US20100298169 Method of patterning molecules on a substrate using a micro-contact printing process
11/25/2010US20100298167 Novel cell lines expressing enac and methods using them
11/25/2010US20100298166 Cell populations for polypeptide analysis and uses of same
11/25/2010US20100298154 Method for Categorizing Samples Containing Spermatozoa by Molecular Profiling
11/25/2010US20100298146 S-adenosylmethionine synthetase expression elements identified from arabidopsis thaliana
11/25/2010US20100297771 Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants, and nutrient medium used therefor
11/25/2010US20100297770 Liquid-based method for producing plant embryos
1 ... 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 ... 1827